Search

Your search keyword '"Youle, Mike"' showing total 305 results

Search Constraints

Start Over You searched for: Author "Youle, Mike" Remove constraint Author: "Youle, Mike"
305 results on '"Youle, Mike"'

Search Results

1. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial

2. Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial

4. A tale of two countries: all‐cause mortality among people living with HIV and receiving combination antiretroviral therapy in the UK and Canada

5. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial

12. Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV

14. British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.)

17. Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting:The RESPOND cohort consortium

19. Two-year outcome of a multidrug regiment in patients who did not respond to a protease inhibitor regimen

21. Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study

22. The effect of HIV status on the frequency and severity of acute respiratory illness

27. Depression, lifestyle factors and cognitive function in people living with HIV and comparable HIV-negative controls

28. Level of agreement between frequently used cardiovascular risk calculators in people living with HIV

31. Concomitant Use of an Active Boosted Protease Inhibitor with Enfuvirtide in Treatment-Experienced, HIV-Infected Individuals: Recent Data and Consensus Recommendations

42. Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 trial

Catalog

Books, media, physical & digital resources